Location History:
- Burlingame, CA (US) (2020)
- San Diego, CA (US) (2022 - 2023)
Company Filing History:
Years Active: 2020-2023
Title: Dana Duey: Innovator in Monoclonal Antibodies
Introduction
Dana Duey is a prominent inventor based in San Diego, California. She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of three patents to her name, Dana's work focuses on therapeutic and diagnostic methods for various diseases.
Latest Patents
Dana's latest patents include groundbreaking inventions such as anti-CD115 antibodies and anti-CD47 antibodies. The anti-CD115 monoclonal antibodies are designed for use in therapeutic and diagnostic methods aimed at treating cancer, autoimmune diseases, and other health conditions. Similarly, the anti-CD47 monoclonal antibodies provide innovative solutions for the treatment of cancer, ischemic-reperfusion injury, and other diseases.
Career Highlights
Throughout her career, Dana has worked with notable companies such as Ablexis, LLC and Absos, LLC. Her expertise in monoclonal antibody development has positioned her as a key player in the biotechnology sector. Dana's innovative approaches have led to advancements in therapeutic applications that benefit patients worldwide.
Collaborations
Dana has collaborated with esteemed colleagues, including John Lippincott and John A. Lippincott. These partnerships have fostered a collaborative environment that enhances the research and development of her inventions.
Conclusion
Dana Duey is a trailblazer in the field of monoclonal antibodies, with a focus on developing innovative solutions for serious health issues. Her contributions continue to impact the biotechnology industry positively.